Delivery Order SPE2DB22D1017-SPE2DB24FG5RA
Award Date
9/23/24
Potential Completion Date
10/15/24
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,311.50 firm fixed-price delivery order is for the supply of 4,565,177,700 units of the pharmaceutical product Esbriet 267 mg capsules. The contract has an ultimate completion date of August 7, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,171,757 units of the pharmaceutical drug Esbriet 267 mg capsule. The $3,311.50 contract has an ultimate completion date of April 25, 2024 and does not contain a set-aside designation. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Esbriet 267 mg capsules. The contract has a ceiling value of $3,425.95 and is a Firm Fixed Price Delivery Order with a completion date of January 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,311.50 firm fixed-price delivery order is for Esbriet 267 mg capsules, a specialty medication. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Esbriet 267 mg capsules. The award, valued at $3,425.95, has a firm fixed price and an ultimate completion date of March 11, 2025. The contract is not designated as a set-aside award. AmerisourceBergen, the prime contractor, will provide the Esbriet capsules to support military treatment facilities, veterans' healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,311.50 firm fixed price contract is for the supply of the medication Esbriet 267 mg capsules to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the provision of Esbriet 801 mg tablets in quantities of 90. The contract, valued at $13,246.00, is a Firm Fixed Price Delivery Order with a completion date of June 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Esbriet 801 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $3,311.50 and a ceiling value of $3,311.50. The contract has an ultimate completion date of May 20, 2024. Amerisourcebergen Drug Corp is the prime contractor, and its parent company is Cencora, Inc. (doing business as Amerisourcebergen). This...
This federal contract award, valued at $3,425.95, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on November 29, 2024. The contract is a delivery order for the pharmaceutical product Esbriet 801 mg tablet, with an ultimate completion date of December 20, 2024. The contract type is firm fixed price. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.95, is a firm fixed-price delivery order for the supply of ESBRIET 267 MG CAPSULE 270S. The contract has an ultimate completion date of April 25, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...